These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 7694306

  • 1. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E, Svestka J.
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [Abstract] [Full Text] [Related]

  • 2. Risperidone: clinical safety and efficacy in schizophrenia.
    Borison RL, Pathiraja AP, Diamond BI, Meibach RC.
    Psychopharmacol Bull; 1992 Jul; 28(2):213-8. PubMed ID: 1381102
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I, Ravanić D, Popović V, Vladejić S, Stanojević A, Stojanović M.
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [Abstract] [Full Text] [Related]

  • 7. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
    Potkin SG, Litman RE, Torres R, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S4-11. PubMed ID: 18334911
    [Abstract] [Full Text] [Related]

  • 9. Risperidone in the treatment of schizophrenia.
    Marder SR, Meibach RC.
    Am J Psychiatry; 1994 Jun; 151(6):825-35. PubMed ID: 7514366
    [Abstract] [Full Text] [Related]

  • 10. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
    Byerly MJ, Nakonezny PA, Rush AJ.
    Psychiatry Res; 2008 May 30; 159(1-2):115-20. PubMed ID: 18295343
    [Abstract] [Full Text] [Related]

  • 11. Risperidone in adolescents.
    Cozza SJ, Edison DL.
    J Am Acad Child Adolesc Psychiatry; 1994 Oct 30; 33(8):1211. PubMed ID: 7527022
    [No Abstract] [Full Text] [Related]

  • 12. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
    Delcker A, Schoon ML, Oczkowski B, Gaertner HJ.
    Pharmacopsychiatry; 1990 May 30; 23(3):125-30. PubMed ID: 1973843
    [Abstract] [Full Text] [Related]

  • 13. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
    López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL, González Pinto A, Eguiluz I, Fernández A.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996 May 30; 24(4):165-72. PubMed ID: 8984849
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM, Lauriello J, Laska E, Di Marino M, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr 30; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [Abstract] [Full Text] [Related]

  • 15. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.
    Chin CN, Hamid AR, Philip G, Ramlee T, Mahmud M, Zulkifli G, Loh CC, Zakariah MS, Norhamidah MS, Suraya Y, Roslan KA, Chandramohan P, Cheah YC, Leonard AO.
    Med J Malaysia; 1998 Dec 30; 53(4):365-71. PubMed ID: 10971979
    [Abstract] [Full Text] [Related]

  • 16. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
    Czobor P, Volavka J.
    J Clin Psychopharmacol; 1993 Oct 30; 13(5):332-42. PubMed ID: 7693770
    [Abstract] [Full Text] [Related]

  • 17. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
    Hebenstreit GF, Laux G, Schubert H, Beckmann H, Amman J, Bunse J, Eikmeier G, Geretsegger C, Kanitz RD, Kanzow WT.
    Pharmacopsychiatry; 1991 Sep 30; 24(5):153-8. PubMed ID: 1685572
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
    Möller HJ, Pelzer E, Kissling W, Riehl T, Wernicke T.
    Pharmacopsychiatry; 1991 Nov 30; 24(6):185-9. PubMed ID: 1725925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.